Ipamorelin 10mg (10 vials/Kit): Selective Growth Hormone Secretagogue for Research

Ipamorelin is a synthetic pentapeptide  belonging to the growth hormone secretagogue (GHS) class. Operating as a highly selective agonist at the growth hormone secretagogue receptor 1a (GHSR-1a / ghrelin receptor), Ipamorelin mimics the physiological action of endogenous ghrelin to stimulate pulsatile growth hormone (GH) release from the anterior pituitary gland. Sourcing Ipamorelin 10mg (10 vials/Kit) provides biotechnology institutions, academic laboratories, and clinical researchers with a high-purity analytical reagent engineered to investigate somatotropic axis kinetics, nitrogen retention, bone mineral density, and tissue repair pathways without unwanted endocrine off-target activity.

Unlike earlier ghrelin mimetics and growth hormone-releasing peptides (such as GHRP-2 or GHRP-6), Ipamorelin is distinguished by its exceptional receptor selectivity. In vitro and in vivo studies demonstrate that Ipamorelin stimulates growth hormone secretion without causing significant elevations in plasma cortisol, adrenocorticotropic hormone (ACTH), aldosterone, or prolactin, even at high physiological dosages. This high specificity eliminates confounding stress-hormone variables in metabolic assays. Utilizing the standardized Ipamorelin 10mg (10 vials/Kit) format ensures consistent dosing protocols across longitudinal trials evaluating body composition and cellular regeneration.

Maintaining strict batch uniformity and chemical stability is essential for quantitative hormonal bioassays. The Ipamorelin 10mg (10 vials/Kit) configuration delivers 100mg of total high-purity active material distributed across ten individual 10mg USP Type I borosilicate glass vials. Freeze-dried under sterile vacuum conditions, each vial contains a uniform, highly stable lyophilized powder cake. This multi-vial kit format allows researchers to reconstitute only the active working volume required for immediate experimental runs, preserving remaining vials under deep freeze stasis to avoid degradation caused by repeated freeze-thaw cycles.

Selective Receptor Agonism, Endocrine Kinetics, and Technical Specifications

The primary research value of Ipamorelin 10mg (10 vials/Kit) stems from its unique binding profile at the central ghrelin receptor and its favorable pharmacokinetic behavior:

• High GHSR-1a Selectivity: Binds directly to the growth hormone secretagogue receptor 1a with nanomolar affinity, triggering intracellular calcium influx and somatotrope GH release.

• Minimal Off-Target Endocrine Effects: Does not significantly alter plasma cortisol, ACTH, prolactin, or thyroid-stimulating hormone (TSH) levels, isolating pure growth hormone activity.

• Pulsatile GH Release Dynamics: Mimics natural biological GH secretion spikes rather than creating continuous baseline elevations, reducing receptor desensitization and down-regulation risk.

• Anabolic & Metabolic Modulation: Facilitates research into increased muscle protein synthesis, enhanced lipolysis, improved bone mineral accretion, and accelerated collagen turnover.

• Ultra-High Chemical Purity ($\ge$99.0%): Manufactured via automated Solid-Phase Peptide Synthesis (SPPS) and purified using preparative High-Performance Liquid Chromatography (HPLC) to ensure complete removal of truncated fragments and residual reagents.

Reconstitution Guidelines, Laboratory Storage Standards, and Quality Protocols

Achieving reproducible, publication-grade results when working with Ipamorelin 10mg (10 vials/Kit) requires strict adherence to standardized aseptic laboratory preparation and climate-controlled storage protocols.

Perform all reconstitution procedures inside a certified Class II Biosafety Cabinet:

1. Temperature Equilibration: Allow the frozen Ipamorelin 10mg (10 vials/Kit) vial to reach room temperature prior to solvent addition to prevent atmospheric moisture condensation inside the glass container.

2. Septum Sanitization: Remove the protective plastic flip-cap and thoroughly wipe the synthetic rubber stopper with a fresh 70% isopropyl alcohol pad. Allow the surface to air-dry completely.

3. Slow Diluent Addition: Using a sterile syringe equipped with a fine-gauge needle, draw the required volume of Bacteriostatic Water (0.9% benzyl alcohol), Sterile Normal Saline (0.9% NaCl), or Phosphate-Buffered Saline (PBS). Direct the stream against the inner glass wall so it slowly trickles over the lyophilized cake.

4. Gentle Hydration: Allow the diluent to fully hydrate the powder cake for 2 minutes. Gently roll the vial between your palms or swirl in smooth circular motions until clear. Never vortex or shake vigorously, as turbulent agitation can shear peptide bonds and induce protein foaming.

5. Micro-Aliquot Strategy: For multi-week testing protocols, divide reconstituted solution into sterile, single-use microcentrifuge tubes under aseptic conditions to prevent atmospheric oxidation and eliminate repeated freeze-thaw cycles.

Batch Quality Documentation & Traceability: Every production lot of Ipamorelin 10mg (10 vials/Kit) undergoes third-party analytical testing. High-Performance Liquid Chromatography (HPLC) chromatograms confirm individual component purity exceeding 99.0%, while Electrospray Ionization Mass Spectrometry (ESI-MS) confirms precise molecular mass. Each shipment includes a batch-specific Certificate of Analysis (COA) documenting chemical purity, residual solvent analysis, heavy metal screens, and bacterial endotoxin levels (<0.05 EU/mg) to satisfy institutional compliance requirements.

Strict Regulatory & Research Compliance Statement: Ipamorelin 10mg (10 vials/Kit) is produced, packaged, and distributed exclusively for in vitro laboratory research, academic experimentation, chemical synthesis, and preclinical research. Ipamorelin 10mg (10 vials/Kit) is strictly not intended, formulated, or approved for human or animal consumption, therapeutic medical treatment, clinical diagnostic work, or cosmetic applications. All handling must be conducted by certified research personnel operating within equipped laboratory facilities in compliance with OSHA workplace safety regulations and institutional biosafety protocols.